Similarly, high levels of tissue type plasminogen activator (tPA) as well as high expression of hepsin (HPN) have previously been associated with an increased risk of CRC recurrence and shortened PFS [26, 27]. This evidence concerns the gene HPN and colorectal carcinoma.